DiscoverStartupsRevance TherapeuticsRevance Therapeutics Funding Rounds, Valuation & Investors
Revance Therapeutics company logo
Revance Therapeutics
Actively Hiring
Revance is a biotechnology company setting the new standard in healthcare501-1000 Employees
  • B2C
  • Public Stage
    Publicly traded company

Revance Therapeutics Funding

$113.6M
44 rounds
Revance Therapeutics is active in the following markets / industries: biotechnology, health care and FinTech. The company has secured funding across 4 rounds, totaling in an amount of $113.6M. Their most recent funding was raised on October 24, 2013.

Funding Rounds

U
$10000000
U
$33000000
D
$45000000
D
$25600000

Investors of Revance Therapeutics

Medicis Pharmaceutical
Pac-Link
Avatar for Pac-Link
Bio*One Capital
Avatar for Bio*One Capital
Shepherd Ventures
Avatar for Shepherd Ventures
Technology Partners
Avatar for Technology Partners
Education space providing innovative and tested solutions in Kenya
LLC
Custom Living
Vivo Capital
CNF Investments
Avatar for CNF Investments
Rounds
D
Palo Alto Investors
Avatar for Palo Alto Investors
Rounds
D
Log in or sign up to view more investors